(Q38441938)

English

No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia

scientific article published on June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia (English)

1 reference

Europe PubMed Central

3 September 2017

author name string

Janez Jazbec

1

1 reference

Europe PubMed Central

3 September 2017

Lidija Kitanovski

2

1 reference

Europe PubMed Central

3 September 2017

Richard Aplenc

3

1 reference

Europe PubMed Central

3 September 2017

Marusa Debeljak

4

1 reference

Europe PubMed Central

3 September 2017

Vita Dolzan

5

1 reference

Europe PubMed Central

3 September 2017

publication date

1 June 2005

1 reference

Europe PubMed Central

3 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

3 September 2017

46

1 reference

Europe PubMed Central

3 September 2017

6

1 reference

Europe PubMed Central

3 September 2017

893-897

1 reference

Europe PubMed Central

3 September 2017

Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Second cancers among long-term survivors of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Second malignancy after treatment of childhood non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Malignant lymphoma associated with rheumatoid arthritis, developing shortly after initiation of oral methotrexate

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Association of CYP3A4 genotype with treatment-related leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Worldwide distribution of a common methylenetetrahydrofolate reductase mutation

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

1 reference

https://api.crossref.org/works/10.1080%2F10428190500086428

21 January 2018

Identifiers

10.1080/10428190500086428

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38441938&oldid=1760079394"